Aeterna Zentaris
AEZS
#10766
Rank
โ‚ฌ15.95 M
Marketcap
5,21ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -1,90ย โ‚ฌ

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -1,87ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,26ย โ‚ฌ a decrease over its 2021 EPS that were of -1,66ย โ‚ฌ.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-1,90ย โ‚ฌ
2022-4,26ย โ‚ฌ157.14%
2021-1,66ย โ‚ฌ-41.48%
2020-2,83ย โ‚ฌ-64.46%
2019-7,97ย โ‚ฌ-240%
20185,69ย โ‚ฌ-122.32%
2017-25,51ย โ‚ฌ-53.53%
2016-54,90ย โ‚ฌ-86.71%
2015-413,23ย โ‚ฌ-35.21%
2014-637,84ย โ‚ฌ-216.67%
2013546,72ย โ‚ฌ-123.3%
2012-2.346ย โ‚ฌ-40.8%
2011-3.964ย โ‚ฌ-6.45%
2010-4.237ย โ‚ฌ-27.91%
2009-5.877ย โ‚ฌ-61.61%
2008-15.308ย โ‚ฌ83.61%
2007-8.337ย โ‚ฌ-195.31%
20068.748ย โ‚ฌ178.26%
20053.144ย โ‚ฌ-330%
2004-1.367ย โ‚ฌ-80.05%
2003-6.851ย โ‚ฌ17.78%
2002-5.817ย โ‚ฌ515.93%
2001-944,41ย โ‚ฌ-68.6%
2000-3.008ย โ‚ฌ137.48%
1999-1.267ย โ‚ฌ-3.63%
1998-1.314ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,78ย โ‚ฌ-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1,80ย โ‚ฌ-196.66%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,33ย โ‚ฌ-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
3,21ย โ‚ฌ-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA